Copyright
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Orthop. Jul 18, 2020; 11(7): 319-327
Published online Jul 18, 2020. doi: 10.5312/wjo.v11.i7.319
Published online Jul 18, 2020. doi: 10.5312/wjo.v11.i7.319
Current concepts in the surgical treatment of skeletal metastases
Jessica Ehne, Panagiotis Tsagozis, Department of Orthopedic Surgery, Karolinska University Hospital, Solna 171 76, Sweden
Author contributions: Both Ehne J and Tsagozis P performed literature searches, contributed to the intellectual input and writing.
Conflict-of-interest statement: No conflicts of interest to declare.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Jessica Ehne, MD, Surgeon, Department of Orthopedic Surgery, Karolinska University Hospital, Eugeniavägen 3, Solna 171 76, Sweden. jessica.ehne@sll.se
Received: February 28, 2020
Peer-review started: February 28, 2020
First decision: April 29, 2020
Revised: May 20, 2020
Accepted: May 30, 2020
Article in press: May 30, 2020
Published online: July 18, 2020
Peer-review started: February 28, 2020
First decision: April 29, 2020
Revised: May 20, 2020
Accepted: May 30, 2020
Article in press: May 30, 2020
Published online: July 18, 2020
Core Tip
Core tip: Patients with metastatic bone disease are a heterogenous group. Complication rates are higher than for the native fracture group. To avoid unnecessary complications, preoperative planning is crucial and allows correct surgical timing. Adjuvant treatment should be considered.